Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2020 253
2021 2135
2022 3777
2023 2251
2024 529

Text availability

Article attribute

Article type

Publication date

Search Results

7,840 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC. Meo SA, et al. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877. Eur Rev Med Pharmacol Sci. 2021. PMID: 33629336 Free article. Review.
However, some associated allergic symptoms have been reported for both vaccines. The COVID-19 vaccines can cause mild adverse effects after the first or second doses, including pain, redness or swelling at the site of vaccine shot, fever, …
However, some associated allergic symptoms have been reported for both vaccines. The COVID-19 vaccines can cause …
Covid-19 vaccines and variants of concern: A review.
Hadj Hassine I. Hadj Hassine I. Rev Med Virol. 2022 Jul;32(4):e2313. doi: 10.1002/rmv.2313. Epub 2021 Nov 9. Rev Med Virol. 2022. PMID: 34755408 Free PMC article. Review.
Although many Covid-19 vaccines have been developed, additional effective vaccines are still needed to meet the global demand. Promising Covid-19 vaccines such as WIBP-CorV, AD5-nCOV, ZyCoV-D, CVnCoV, EpiVacCorona and ZF2001 have a …
Although many Covid-19 vaccines have been developed, additional effective vaccines are still needed to meet the …
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape.
Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Tregoning JS, et al. Nat Rev Immunol. 2021 Oct;21(10):626-636. doi: 10.1038/s41577-021-00592-1. Epub 2021 Aug 9. Nat Rev Immunol. 2021. PMID: 34373623 Free PMC article. Review.
Where 2020 saw the development and testing of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at an unprecedented pace, the first half of 2021 has seen vaccine rollout in many countries. ...Where they have been deployed in a high proportion of …
Where 2020 saw the development and testing of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at an unp …
COVID-19 vaccine development: milestones, lessons and prospects.
Li M, Wang H, Tian L, Pang Z, Yang Q, Huang T, Fan J, Song L, Tong Y, Fan H. Li M, et al. Signal Transduct Target Ther. 2022 May 3;7(1):146. doi: 10.1038/s41392-022-00996-y. Signal Transduct Target Ther. 2022. PMID: 35504917 Free PMC article. Review.
However, some viral vector or mRNA vaccines may be associated with complications like thrombocytopenia and myocarditis, raising concerns about the safety of these COVID-19 vaccines. Here, we systemically assess the safety and efficacy of COVID- …
However, some viral vector or mRNA vaccines may be associated with complications like thrombocytopenia and myocarditis, raising conce …
Safety of COVID-19 vaccines.
Al Khames Aga QA, Alkhaffaf WH, Hatem TH, Nassir KF, Batineh Y, Dahham AT, Shaban D, Al Khames Aga LA, Agha MYR, Traqchi M. Al Khames Aga QA, et al. J Med Virol. 2021 Dec;93(12):6588-6594. doi: 10.1002/jmv.27214. Epub 2021 Jul 28. J Med Virol. 2021. PMID: 34270094 Free PMC article. Clinical Trial.
This study is aimed to identify the adverse effects associated with three types of coronavirus disease 2019 vaccines. ...Pfizer, AstraZeneca, and Sinopharm vaccines were found to be safe and Sinopharm vaccine showed a lower prevalence of adverse …
This study is aimed to identify the adverse effects associated with three types of coronavirus disease 2019 vaccines. . …
COVID-19 vaccines mix-and-match: The concept, the efficacy and the doubts.
Rashedi R, Samieefar N, Masoumi N, Mohseni S, Rezaei N. Rashedi R, et al. J Med Virol. 2022 Apr;94(4):1294-1299. doi: 10.1002/jmv.27463. Epub 2021 Nov 30. J Med Virol. 2022. PMID: 34796525 Free PMC article. Review.
The search for developing effective vaccines against SARS-CoV-2 began with the start of the COVID-19 pandemic, and the first vaccine dose was administered in December 2020. ...Some adverse reactions have resulted in the discontinuation of the specific …
The search for developing effective vaccines against SARS-CoV-2 began with the start of the COVID-19 pandemic, and the …
Should children be vaccinated against COVID-19?
Solanke F, Easton S, Selby A, James D, Roberts G. Solanke F, et al. Arch Dis Child. 2022 Mar;107(3):e1-e7. doi: 10.1136/archdischild-2021-323389. Epub 2021 Nov 3. Arch Dis Child. 2022. PMID: 34732388 Review.
Whether all children under 12 years of age should be vaccinated against COVID-19 remains an ongoing debate. The relatively low risk posed by acute COVID-19 in children, and uncertainty about the relative harms from vaccination and disease mean that the …
Whether all children under 12 years of age should be vaccinated against COVID-19 remains an ongoing debate. The relatively low …
Efficacy and safety of COVID-19 vaccines in older people.
Soiza RL, Scicluna C, Thomson EC. Soiza RL, et al. Age Ageing. 2021 Feb 26;50(2):279-283. doi: 10.1093/ageing/afaa274. Age Ageing. 2021. PMID: 33320183 Free PMC article. Review.
Several vaccines against coronavirus disease 2019 (COVID-19) are on the cusp of regulatory approval. ...Overall, the sparse data from Phase II trials suggest a reduction in both antibody responses and mild to moderate adverse events in well older peopl …
Several vaccines against coronavirus disease 2019 (COVID-19) are on the cusp of regulatory approval. ...Overall, the sp …
COVID-19 Vaccines.
Hahn WO, Wiley Z. Hahn WO, et al. Infect Dis Clin North Am. 2022 Jun;36(2):481-494. doi: 10.1016/j.idc.2022.01.008. Epub 2022 Jan 31. Infect Dis Clin North Am. 2022. PMID: 35636910 Free PMC article. Review.
This article is a narrative review of the rapidly moving coronavirus disease 2019 vaccine field with an emphasis on clinical efficacy established in both randomized trials and postmarketing surveillance of clinically available vaccines. We review the major clinical trials …
This article is a narrative review of the rapidly moving coronavirus disease 2019 vaccine field with an emphasis on clinical efficacy establ …
The efficacy and effectiveness of COVID-19 vaccines around the world: a mini-review and meta-analysis.
Soheili M, Khateri S, Moradpour F, Mohammadzedeh P, Zareie M, Mortazavi SMM, Manifar S, Kohan HG, Moradi Y. Soheili M, et al. Ann Clin Microbiol Antimicrob. 2023 May 19;22(1):42. doi: 10.1186/s12941-023-00594-y. Ann Clin Microbiol Antimicrob. 2023. PMID: 37208749 Free PMC article. Review.
OBJECTIVES: This meta-analysis evaluated the Efficacy and Effectiveness of several COVID-19 vaccines, including AstraZeneca, Pfizer, Moderna, Bharat, and Johnson & Johnson, to better estimate their immunogenicity, benefits, or side effects. METHODS …
OBJECTIVES: This meta-analysis evaluated the Efficacy and Effectiveness of several COVID-19 vaccines, including AstraZe …
7,840 results